Non-drug treatment for hypertension found effective in hard-to-control refractory hypertensives

June 30, 2003

Fort Lee, NJ -- June 30, 2003 Hard-to-control refractory hypertensives witnessed a significant blood pressure reduction when using a new non-drug treatment device, Resperate®, according to a study published in this month's American Journal of Hypertension.

The 8-week study, performed at the WHO Collaborative Center for Prevention of CVD, the Barzilai Medical Center Ashkelon, Israel, demonstrated that 15-minutes daily self treatment with the Resperate device significantly reduced the blood pressure of patients who were not achieving goal blood pressure despite taking 3 or more antihypertensive drugs at maximum dosage.

The results of the American Journal of Hypertension study are consistent with outcomes reported in six previous peer-reviewed, published studies examining the effects of the device in the general uncontrolled hypertensive patient population and a recent mechanism-of-action review published in the American Heart Association's textbook, Hypertension Primer in May, 2003.

"These are evidence of the effectiveness of Resperate as an adjunctive treatment for hypertension" said Dr. Reuven Viskoper, the principal investigator and the past president of the Israeli Society of Hypertension. "The fact that this non-drug treatment delivered the same significant blood pressure reductions even in refractory hypertensives is clinically meaningful as it provides us with a much needed effective, and side-effect-free treatment option for this patient population".
-end-
Reprints of the full text article, other peer reviewed articles and additional information about Resperate are available on request from Tom Kirwan at 201-720-7750, ext. 7136 or see http://www.resperate.com/press.

About InterCure Ltd. & Resperate® InterCure (www.intercure.com) is a medical device company pioneering the application of respiratory-pacing technology for the treatment of hypertension and heart failure. Following six successful clinical trials, Resperate http://www1.resperate.com/, InterCure's first product, became the only FDA-cleared, non-drug medical device indicated for the adjunctive treatment of hypertension. Resperate can be safely added to lifestyle modifications and/or pharmacological therapy. Resperate's blood pressure reductions are in addition to other treatments.

InterCure

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.